Engineered plant-derived extracellular vesicles for targeted regulation and treatment of colitis-associated inflammation.

ABSTRACT: Rationale: Inflammatory bowel disease (IBD) is a chronic disorder characterized by persistent inflammation of the gastrointestinal tract. Due to the elusive causes and complex mechanisms of this disorder, the development of highly effective therapeutic drugs is crucial. Extracellular vesicles (EVs) are small membrane-bound structures released by cells into the surrounding environment. Recent research has witnessed a substantial surge in the utilization of plant-derived EVs that offer advantages such as high productivity, low production costs, diverse biological functions, and low cytotoxicity. Herein, Red cabbage-derived EVs (Rabex) were investigated and engineered as potential therapeutic agents for IBD. Methods: Rabex was engineered by surface conjugation with hyaluronic ac

SUBMITTER: Kang SJ 

PROVIDER: S-EPMC11413791 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature